SCHEMBL5606479

SCHEMBL5606479

NC(=Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 2/20 0.53
CISD1 Q9NZ45 2/20 0.53
CYP3A4 P08684 2/20 0.53
HPGD P15428 2/20 0.53
SLC16A3 O15427 1/20 0.53
SLC16A1 P53985 1/20 0.53
GPR35 Q9HC97 1/20 0.53
ESR1 P03372 4/20 0.47
ESR2 Q92731 3/20 0.47
TYR P14679 2/20 0.47
PKM P14618 2/20 0.47
AKR1B10 O60218 2/20 0.47
AKR1B1 P15121 2/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA3 P07451 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903998 1.00 ALDH1A1 (0.53) ALDH1A1KDM4ECISD1CYP3A4HPGD
SCHEMBL11729242 0.83 EGFR (0.53) ALDH1A1KDM4EALDH5A1ABATEGFR
SCHEMBL792779 0.82 AKR1C3 (0.56) ALDH1A1KDM4ECYP3A4HPGDHCAR2
SCHEMBL1081471 0.82 AKR1C3 (0.56) ALDH1A1KDM4ECYP3A4HPGDHCAR2
SCHEMBL5982913 0.82 AKR1C3 (0.56) ALDH1A1KDM4ECYP3A4HPGDHCAR2
SCHEMBL1462507 0.78 EGFR (0.57) ALDH1A1KDM4ECYP3A4HPGDPKM
SCHEMBL1462505 0.78 EGFR (0.57) ALDH1A1KDM4ECYP3A4HPGDPKM
SCHEMBL30692896 0.78 EGFR (0.57) ALDH1A1KDM4ECYP3A4HPGDPKM
SCHEMBL2506329 0.77 KDM4E (0.57) ALDH1A1KDM4ECISD1CYP3A4HPGD
SCHEMBL1704759 0.77 ALDH1A1 (0.65) ALDH1A1KDM4ECISD1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117790786-A Lithium ion battery negative electrode material and preparation method thereof 江苏欧力特能源科技有限公司 2024-03-29 CN claimed
CN-114539362-A Botulinum toxin specific substrate peptide, detection kit and detection method 中国疾病预防控制中心传染病预防控制所 2022-05-27 CN claimed
CN-103163736-A Composition including polyamide acid for forming lower layer reflection preventing film NISSAN CHEMICAL IND LTD 2013-06-19 CN claimed
CN-101010634-A Composition for forming lower layer antireflection film containing polyamic acid NISSAN CHEMICAL IND LTD (JP) 2007-08-01 CN claimed
CN-117790786-A Lithium ion battery negative electrode material and preparation method thereof 江苏欧力特能源科技有限公司 2024-03-29 CN disclosed
US-11118011-B2 Biocompatible polymers for medical devices RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-09-14 US disclosed
EP-3461855-B1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES UNIV RUTGERS (US) 2020-05-27 EP disclosed
US-20190185624-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2019-06-20 US disclosed
EP-3461855-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES Rutgers, The State University of New Jersey (US) 2019-04-03 EP disclosed
US-10202490-B2 Biocompatible polymers for medical devices RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-02-12 US disclosed
EP-2486081-B1 BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES UNIV RUTGERS (US) 2018-12-05 EP disclosed
US-20170158819-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2017-06-08 US disclosed
US-9605112-B2 Biocompatible polymers for medical devices RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2017-03-28 US disclosed
CN-103163736-A Composition including polyamide acid for forming lower layer reflection preventing film NISSAN CHEMICAL IND LTD 2013-06-19 CN disclosed
US-20120226013-A1 BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-09-06 US disclosed
EP-2486081-A1 BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES Rutgers, The State University of New Jersey (US) 2012-08-15 EP disclosed
CN-101010634-A Composition for forming lower layer antireflection film containing polyamic acid NISSAN CHEMICAL IND LTD (JP) 2007-08-01 CN disclosed
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120226013-A1 BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES MATR3, MIF, BMP2 ALDH1A1 4752/4885KDM4E 3508/4885CISD1 3636/4885
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR ALDH1A1 5/4885KDM4E 3298/4885CISD1 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.